Congressional Bills
H.R. 3 (Engrossed in House)
131 sections
- PreambleTo establish a fair price negotiation program, protect the Medicare program from excessive price increases, and estab...
- PreambleTo establish a fair price negotiation program, protect the Medicare program from excessive price increases, and estab...
- PreambleTo establish a fair price negotiation program, protect the Medicare program from excessive price increases, and estab...
- PreambleTo establish a fair price negotiation program, protect the Medicare program from excessive price increases, and estab...
- Sec. 1Short title; table of contents
- Sec. 1Short title; table of contents
- Sec. 1Short title; table of contents
- Sec. 1Short title; table of contents
- Sec. 101Providing for lower prices for certain high-priced single source drugs
- Sec. 101Providing for lower prices for certain high-priced single source drugs
- Sec. 101Providing for lower prices for certain high-pricesectiond single source drugs
- Sec. 101Providing for lower prices for certain high-priced single source drugs
- Sec. 102Selected drug manufacturer excise tax imposed during noncompliance periods
- Sec. 102Selected drug manufacturer excise tax imposed during noncompliance periods
- Sec. 102Selected drug manufacturer excise tax imposed during noncompliance periods
- Sec. 102Selected drug manufacturer excise tax imposed during noncompliance periods
- Sec. 103Fair Price Negotiation Implementation Fund
- Sec. 103Fair Price Negotiation Implementation Fund
- Sec. 201Medicare part B rebate by manufacturers
- Sec. 201Medicare part B rebate by manufacturers
- Sec. 201Medicare part B rebate by manufacturers
- Sec. 201Medicare part B rebate by manufacturers
- Sec. 202Medicare part D rebate by manufacturers
- Sec. 202Medicare part D rebate by manufacturers
- Sec. 202Medicare part D rebate by manufacturers
- Sec. 202Medicare part D rebate by manufacturers
- Sec. 203Provision regarding inflation rebates for group health plans and group health insurance coverage
- Sec. 203Provision regarding inflation rebates for group health plans and group health insurance coverage
- Sec. 204Annual report on drug costs in group health plans and group health insurance coverage
- Sec. 204Annual report on drug costs in group health plans and group health insurance coverage
- Sec. 205Collection of data
- Sec. 205Collection of data
- Sec. 301Medicare part D benefit redesign
- Sec. 301Medicare part D benefit redesign
- Sec. 301Medicare part D benefit redesign
- Sec. 301Medicare part D benefit redesign
- Sec. 302Allowing certain enrollees of prescription drugs plans and MA–PD plans under Medicare program to spread out cost-sharing under certain circumstances
- Sec. 302Allowing certain enrollees of prescription drugs plans and MA–PD plans under Medicare program to spread out cost-sharing under certain circumstances
- Sec. 302Allowing certain enrollees of prescription drugs plans and MA–PD plans under Medicare program to spread out cost-sharing under certain circumstances
- Sec. 303Establishment of pharmacy quality measures under Medicare part D
- Sec. 303Establishment of pharmacy quality measures under Medicare part D
- Sec. 303Establishment of pharmacy quality measures under Medicare part D
- Sec. 401Drug price transparency
- Sec. 401Adjustments to Medicare part D cost-sharing reductions for low-income individuals
- Sec. 401Drug price transparency
- Sec. 402Dissemination to Medicare part D subsidy eligible individuals of information comparing premiums of certain prescription drug plans
- Sec. 403Providing for intelligent assignment of certain subsidy eligible individuals auto-enrolled under Medicare prescription drug plans and MA–PD plans
- Sec. 404Expanding eligibility for low-income subsidies under part D of the Medicare program
- Sec. 405Automatic eligibility of certain low-income territorial residents for premium and cost-sharing subsidies under the Medicare program; Sunset of enhanced allotment program
- Sec. 406Automatic qualification of certain Medicaid beneficiaries for premium and cost-sharing subsidies under part D of the Medicare program
- Sec. 407Eliminating the resource requirement with respect to subsidy eligible individuals under part D of the Medicare program
- Sec. 501Dissemination to Medicare part D subsidy eligible individuals of information comparing premiums of certain prescription drug plans
- Sec. 501Drug price transparency
- Sec. 501Dissemination to Medicare part D subsidy eligible individuals of information comparing premiums of certain prescription drug plans
- Sec. 502Providing for intelligent assignment of certain subsidy eligible individuals auto-enrolled under Medicare prescription drug plans and MA–PD plans
- Sec. 502Providing for intelligent assignment of certain subsidy eligible individuals auto-enrolled under Medicare prescription drug plans and MA–PD plans
- Sec. 503Expanding eligibility for low-income subsidies under part D of the Medicare program
- Sec. 503Expanding eligibility for low-income subsidies under part D of the Medicare program
- Sec. 504Automatic eligibility of certain low-income territorial residents for premium and cost-sharing subsidies under the Medicare program; Sunset of enhanced allotment program
- Sec. 504Automatic eligibility of certain low-income territorial residents for premium and cost-sharing subsidies under the Medicare program; Sunset of enhanced allotment program
- Sec. 505Automatic qualification of certain Medicaid beneficiaries for premium and cost-sharing subsidies under part D of the Medicare program
- Sec. 505Automatic qualification of certain Medicaid beneficiaries for premium and cost-sharing subsidies under part D of the Medicare program
- Sec. 506Providing for certain rules regarding the treatment of eligible retirement plans in determining the eligibility of individuals for premium and cost-sharing subsidies under part D of the Medicare program
- Sec. 506Providing for certain rules regarding the treatment of eligible retirement plans in determining the eligibility of individuals for premium and cost-sharing subsidies under part D of the Medicare program
- Sec. 507Reducing cost-sharing and other program improvements for low-income beneficiaries
- Sec. 507Reducing cost-sharing and other program improvements for low-income beneficiaries
- Sec. 601Dental and oral health care
- Sec. 601Temporary increase in Medicare part B payment for certain biosimilar biological products
- Sec. 601Dental and oral health care
- Sec. 602Providing coverage for hearing care under the Medicare program
- Sec. 602Providing coverage for hearing care under the Medicare program
- Sec. 603Providing coverage for vision care under the Medicare program
- Sec. 603Providing coverage for vision care under the Medicare program
- Sec. 701NIH Innovation Initiatives
- Sec. 701NIH Innovation Initiatives
- Sec. 702NIH clinical trial
- Sec. 702NIH clinical trial
- Sec. 703Innovation Network
- Sec. 703Innovation Network
- Sec. 711Food and Drug Administration
- Sec. 711Food and Drug Administration
- Sec. 712Study on high-risk, high-reward drugs
- Sec. 712Study on high-risk, high-reward drugs
- Sec. 721Opioid Epidemic Response Fund
- Sec. 721Opioid Epidemic Response Fund
- Sec. 722Substance Abuse and Mental Health Services Administration
- Sec. 722Substance Abuse and Mental Health Services Administration
- Sec. 723Centers for Disease Control and Prevention
- Sec. 723Centers for Disease Control and Prevention
- Sec. 724Food and Drug Administration
- Sec. 724Food and Drug Administration
- Sec. 725National Institutes of Health
- Sec. 725National Institutes of Health
- Sec. 726Health Resources and Services Administration
- Sec. 726Health Resources and Services Administration
- Sec. 727Administration for Children and Families
- Sec. 727Administration for Children and Families
- Sec. 731Reducing administrative costs and burdens in health care
- Sec. 731Reducing administrative costs and burdens in health care
- Sec. 801Guaranteed issue of certain Medigap policies
- Sec. 801Guaranteed issue of certain Medigap policies
- Sec. 802Reporting requirements for PDP sponsors regarding point-of-sale rejections under Medicare part D
- Sec. 802Reporting requirements for PDP sponsors regarding point-of-sale rejections under Medicare part D
- Sec. 803Providing access to annual Medicare notifications in multiple languages
- Sec. 803Providing access to annual Medicare notifications in multiple languages
- Sec. 804Temporary increase in Medicare part B payment for certain biosimilar biological products
- Sec. 804Temporary increase in Medicare part B payment for certain biosimilar biological products
- Sec. 805Waiving medicare coinsurance for colorectal cancer screening tests
- Sec. 805Waiving medicare coinsurance for colorectal cancer screening tests
- Sec. 806Medicare coverage of certain lymphedema compression treatment items
- Sec. 806Medicare coverage of certain lymphedema compression treatment items
- Sec. 807Physician fee update
- Sec. 807Physician fee update
- Sec. 808Additional community health center funding
- Sec. 808Additional community health center funding
- Sec. 809Grants to improve trauma support services and mental health care for children and youth in educational settings
- Sec. 809Grants to improve trauma support services and mental health care for children and youth in educational settings
- Sec. 810Pathway to Health Careers Act
- Sec. 810Pathway to Health Careers Act
- Sec. 811Home Visiting to Reduce Maternal Mortality and Morbidity Act
- Sec. 811Home Visiting to Reduce Maternal Mortality and Morbidity Act
- Sec. 812Addition of new measures based on access to biosimilar biological products to the 5-star rating system under medicare advantage
- Sec. 812Addition of new measures based on access to biosimilar biological products to the 5-star rating system under medicare advantage
- Sec. 813Sense of Congress regarding the impact of the high cost of prescription drugs on communities of color and persons living in rural or sparsely populated areas of the United States
- Sec. 813Sense of Congress regarding the impact of the high cost of prescription drugs on communities of color and persons living in rural or sparsely populated areas of the United States
- Sec. 814Regulations requiring direct-to-consumer advertisements for prescription drugs and biological products to include truthful and not misleading pricing information
- Sec. 814Regulations requiring direct-to-consumer advertisements for prescription drugs and biological products to include truthful and not misleading pricing information
- Sec. 815Improving transparency and preventing the use of abusive spread pricing and related practices in Medicaid
- Sec. 815Improving transparency and preventing the use of abusive spread pricing and related practices in Medicaid
- Sec. 816Graduate medical education improvements in rural and underserved communities
- Sec. 816Graduate medical education improvements in rural and underserved communities